| In
today’s scenario, the Indian pharmaceutical sector has
been focusing on R&D activities and to enhance their launch
of new products and compete in the highly regulated market.
This situation has led to a large amount of investments in
R&D centers by Indian pharmaceuticals.
To support this cause of developing new formulations, Pam
Pac, with the introduction of the Model ‘MINIBLIS’
blister packing machine offers a versatile solution for producing
all forms of blister packs, vital for R&D testing and
clinical exhibit batches, thus opening up windows of opportunity
for this segment. |